PBSV (Pharma-Bio Serv) Cyclically Adjusted FCF per Share: $0.02 (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PBSV Pharma-Bio Serv Inc PBSV
43 GF Score
Price $0.42
GF Value $0.58
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Pharma-Bio Serv Cyclically Adjusted FCF per Share?

Pharma-Bio Serv PBSV -27.16% 43 Cyclically Adjusted FCF per Share is $0.02 as of Apr. 2026. GuruFocus rates PBSV with a GF Score™ of 43/100 and a GF Value™ of $0.58 (Modestly Undervalued). The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Pharma-Bio Serv's adjusted free cash flow per share for the three months ended in Apr. 2026 was $-0.016. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $0.02 for the trailing ten years ended in Apr. 2026.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was -30.70% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was -24.80% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was -15.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-08-03), Pharma-Bio Serv's current stock price is $0.4225. Pharma-Bio Serv's Cyclically Adjusted FCF per Share for the quarter that ended in Apr. 2026 was $0.02. Pharma-Bio Serv's Cyclically Adjusted Price-to-FCF of today is 21.13.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Pharma-Bio Serv was 60.00. The lowest was 4.64. And the median was 15.50.


Pharma-Bio Serv  (OTCPK:PBSV) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Pharma-Bio Serv's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=0.4225/0.02
=21.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Pharma-Bio Serv was 60.00. The lowest was 4.64. And the median was 15.50.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Pharma-Bio Serv Cyclically Adjusted FCF per Share Related Terms


Pharma-Bio Serv Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Pharma-Bio Serv's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharma-Bio Serv Cyclically Adjusted FCF per Share Chart

Pharma-Bio Serv Annual Data
Trend Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.06 0.06 0.04 0.02 0.02

Pharma-Bio Serv Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.02 0.02 0.02 0.02

PBSV vs MGRX, BFRG, VYND: Cyclically Adjusted FCF per Share Comparison

For the Health Information Services subindustry, Pharma-Bio Serv's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharma-Bio Serv Cyclically Adjusted Price-to-FCF vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Pharma-Bio Serv's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Pharma-Bio Serv's Cyclically Adjusted Price-to-FCF falls into.


PBSV
43GF Score
Pharma-Bio Serv Inc PBSV
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pharma-Bio Serv Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Pharma-Bio Serv's adjusted Free Cash Flow per Share data for the three months ended in Apr. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Apr. 2026 (Change)*Current CPI (Apr. 2026)
=-0.016/333.0200*333.0200
=-0.016

Current CPI (Apr. 2026) = 333.0200.

Pharma-Bio Serv Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201607 -0.018 240.628 -0.025
201610 -0.011 241.729 -0.015
201701 -0.004 242.839 -0.005
201704 -0.041 244.524 -0.056
201707 -0.022 244.786 -0.030
201710 0.025 246.663 0.034
201801 0.065 247.867 0.087
201804 0.007 250.546 0.009
201807 0.073 252.006 0.096
201810 0.017 252.885 0.022
201901 -0.010 251.712 -0.013
201904 -0.037 255.548 -0.048
201907 -0.028 256.571 -0.036
201910 -0.024 257.346 -0.031
202001 0.065 257.971 0.084
202004 -0.069 256.389 -0.090
202007 0.053 259.101 0.068
202010 0.014 260.388 0.018
202101 0.025 261.582 0.032
202104 -0.051 267.054 -0.064
202107 0.019 273.003 0.023
202110 0.042 276.589 0.051
202201 -0.014 281.148 -0.017
202204 -0.020 289.109 -0.023
202207 0.048 296.276 0.054
202210 0.011 298.012 0.012
202301 0.038 299.170 0.042
202304 -0.011 303.363 -0.012
202307 0.042 305.691 0.046
202310 0.013 307.671 0.014
202401 0.032 308.417 0.035
202404 -0.031 313.548 -0.033
202407 -0.029 314.540 -0.031
202410 -0.003 315.664 -0.003
202501 -0.019 317.671 -0.020
202504 -0.013 320.795 -0.013
202507 0.010 323.048 0.010
202510 0.012 0.000
202601 -0.017 325.252 -0.017
202604 -0.016 333.020 -0.016

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of $0.02 mean?
Pharma-Bio Serv (PBSV) has a Cyclically Adjusted FCF per Share of $0.02 as of Apr. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Pharma-Bio Serv and its competitors.
Is Pharma-Bio Serv's Cyclically Adjusted FCF per Share too high?
Pharma-Bio Serv's current Cyclically Adjusted FCF per Share is $0.02. Overall, Pharma-Bio Serv has a GF Score™ of 43/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Pharma-Bio Serv's Cyclically Adjusted FCF per Share compare to MGRX and BFRG?
Pharma-Bio Serv's Cyclically Adjusted FCF per Share of $0.02 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted FCF per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Pharma-Bio Serv and its competitors. Pharma-Bio Serv's current Cyclically Adjusted FCF per Share is $0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharma-Bio Serv stock overvalued right now?
Based on GuruFocus' analysis, Pharma-Bio Serv (PBSV) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.58, compared to a current price of $0.42 — trading 27.2% below its estimated fair value. The current Cyclically Adjusted FCF per Share is $0.02. Pharma-Bio Serv's overall GF Score™ is 43/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Pharma-Bio Serv (PBSV), the current Cyclically Adjusted FCF per Share is $0.02 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pharma-Bio Serv (PBSV) Overvalued in 2026?

Based on GuruFocus' analysis, Pharma-Bio Serv stock appears to be undervalued. The current stock price of $0.42 is trading 27.2% below its estimated GF Value™ of $0.58. GuruFocus considers Pharma-Bio Serv to be Modestly Undervalued.

Key valuation signals for PBSV:

  • Cyclically Adjusted FCF per Share: $0.02
  • GF Value™: $0.58 vs. price of $0.42 (27.2% below fair value)
  • GF Score™: 43/100 with 1 warning sign

No single metric tells the full story. See the PBSV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Pharma-Bio Serv Business Description

Address No. 6 Road 696, Pharma-Bio Serv Building, Dorado, PRI, 00646
Pharma-Bio Serv Inc is a compliance and technology transfer services consulting firm. It also provides microbiological testing services and chemical testing services through its laboratory testing facility in Puerto Rico. It has three reportable segments: Puerto Rico technical compliance consulting which is the key revenue driver; United States technical compliance consulting; and Europe technical compliance consulting. The company offers solutions to the pharmaceutical, chemical, biotechnology, medical devices, cosmetic and food industries, and allied products companies. It generates maximum revenue from Puerto Rico and also has its presence in United States, Europe and Other countries.
43GF Score

Get the complete analysis for PBSV

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.42
Price
$0.58
GF Value